Ken Griffin Biote Corp. Transaction History

Citadel Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$3.25 - $4.28 $46,371 - $61,067	14,268 Added 73.24%	33,749 $135,000
Q1 2025 May 15, 2025	BUY	$3.23 - $6.2 $62,923 - $120,782	19,481 New	19,481 $64,000
Q3 2024 Nov 14, 2024	SELL	$5.33 - $8.36 $193,660 - $303,752	-36,334 Reduced 48.07%	39,254 $219,000
Q2 2024 Aug 14, 2024	BUY	$5.44 - $7.47 $411,198 - $564,642	75,588 New	75,588 $564,000
Q2 2023 Aug 14, 2023	BUY	$5.27 - $6.9 $83,034 - $108,716	15,756 New	15,756 $106,000

Ticker BTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 7,574,270
Market Cap $19.1M
Description
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.